LAB (Standard BioTools) Shiller PE Ratio: (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LAB Standard BioTools Inc LAB
33 GF Score
Price $0.65
GF Value $0.71
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Standard BioTools Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Standard BioTools  (NAS:LAB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Standard BioTools Shiller PE Ratio Related Terms


Standard BioTools Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Standard BioTools's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Standard BioTools Shiller PE Ratio Chart

Standard BioTools Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Standard BioTools Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LAB vs CV, ELMD, CATX: Shiller PE Ratio Comparison

For the Medical Devices subindustry, Standard BioTools's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard BioTools Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Standard BioTools's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Standard BioTools's Shiller PE Ratio falls into.


LAB
33GF Score
Standard BioTools Inc LAB
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Standard BioTools Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Standard BioTools's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Standard BioTools's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.07/333.9520*333.9520
=-0.070

Current CPI (Jun. 2026) = 333.9520.

Standard BioTools Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.680 241.428 -0.941
201612 -0.610 241.432 -0.844
201703 -0.590 243.801 -0.808
201706 -0.580 244.955 -0.791
201709 -0.460 246.819 -0.622
201712 -0.270 246.524 -0.366
201803 -0.340 249.554 -0.455
201806 -0.420 251.989 -0.557
201809 -0.380 252.439 -0.503
201812 -0.360 251.233 -0.479
201903 -0.440 254.202 -0.578
201906 -0.200 256.143 -0.261
201909 -0.190 256.759 -0.247
201912 -0.182 256.974 -0.237
202003 -0.230 258.115 -0.298
202006 -0.180 257.797 -0.233
202009 -0.080 260.280 -0.103
202012 -0.240 260.474 -0.308
202103 -0.250 264.877 -0.315
202106 -0.230 271.696 -0.283
202109 -0.180 274.310 -0.219
202112 -0.120 278.802 -0.144
202203 -0.990 287.504 -1.150
202206 -0.820 296.311 -0.924
202209 -0.370 296.808 -0.416
202212 -0.260 296.797 -0.293
202303 -0.210 301.836 -0.232
202306 -0.220 305.109 -0.241
202309 -0.270 307.789 -0.293
202312 -0.250 306.746 -0.272
202403 -0.270 312.332 -0.289
202406 -0.120 314.175 -0.128
202409 -0.070 315.301 -0.074
202412 -0.090 315.605 -0.095
202503 -0.070 319.799 -0.073
202506 -0.090 322.561 -0.093
202509 -0.090 324.800 -0.093
202512 0.050 324.054 0.052
202603 0.330 330.213 0.334
202606 -0.070 333.952 -0.070

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Standard BioTools (LAB) Overvalued in 2026?

Based on GuruFocus' analysis, Standard BioTools stock appears to be undervalued. The current stock price of $0.65 is trading 8.9% below its estimated GF Value™ of $0.71. GuruFocus considers Standard BioTools to be Fairly Valued.

Key valuation signals for LAB:

  • Shiller PE Ratio:
  • GF Value™: $0.71 vs. price of $0.65 (8.9% below fair value)
  • GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the LAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Standard BioTools Business Description

Other Exchanges FLB:Germany
Address 50 Milk Street, 10th Floor, Boston, MA, USA, 02109
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
33GF Score

Get the complete analysis for LAB

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$0.71
GF Value